Results

Total Results: 1,577 records

Showing results for "therapy".

  1. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/skin-soft-tissue-discussion-guide.docx
    September 01, 2022 - What antibiotics and antibiotic dosages should the practice recommend for treatment of nonpurulent and … What recommendations will the practice make about non-antibiotic therapies for cellulitis? 3.
  2. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/primary-care-based-efforts.pdf
    March 01, 2019 - • The intervention group received calls from pharmacists who conducted a medication therapy assessment … • At these appointments, pharmacists identified drug therapy problems and worked to resolve these … 4.6 encounters per patient over 11 months • Pharmacists identified an average of 10.4 drug therapy … They identified drug therapy problems, including inappropriate medications, adverse reactions, difficulty … adhering to treatments, and financial barriers, and worked to resolve these problems with the retail
  3. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/PrimaryCareEffortsToReduceReadmissions-envscan.pdf
    March 01, 2020 - • The intervention group received calls from pharmacists who conducted a medication therapy assessment … • At these appointments, pharmacists identified drug therapy problems and worked to resolve these … 4.6 encounters per patient over 11 months • Pharmacists identified an average of 10.4 drug therapy … They identified drug therapy problems, including inappropriate medications, adverse reactions, difficulty … adhering to treatments, and financial barriers, and worked to resolve these problems with the retail
  4. Section 5, Table 1 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-5.pdf
    January 01, 2014 - assessed knowledge of adult survivors of childhood cancer about their primary cancer diagnosis and therapies … Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer … psychometric properties of a survey tool designed to evaluate children's level of independence in their CF treatment … , as this may have a direct effect on their involvement in treatment and adherence. … parents were equally likely to answer questions correctly regarding disease characteristics and treatment
  5. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-datasources.pdf
    October 01, 2019 - quality of health services, medical practice patterns, access to healthcare programs, and outcomes of treatments … The large sample size in the NIS enables analyses of rare conditions, uncommon treatments, and special … To evaluate the outcomes of TB therapy, RVCT Follow up Report-2 was added to collect information on … of directly observed therapy, and results of drug susceptibility testing for the final M. … and where, and reason therapy was extended for more than 12 months.
  6. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-fullreport.pdf
    February 01, 2018 - Patient or surrogate decision-maker declined or is unwilling to consent to therapies. 1.I. … Patient or surrogate decision-maker declined or is unwilling to consent to therapies. 1.K. … The current management strategy for treatment of sepsis is goal-directed therapy, with institution of … antimicrobial and hemodynamic (i.e., relating to the forces driving blood flow throughout the body) treatments … and blood pressure; and maintain or restore threshold heart rate (Brierley, et al., 2009). 11 Therapeutic
  7. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
    December 01, 2020 - quality of health services, medical practice patterns, access to healthcare programs, and outcomes of treatments … The large sample size in the NIS enables analyses of rare conditions, uncommon treatments, and special … To evaluate the outcomes of TB therapy, RVCT Follow up Report-2 was added. … This report collects information on the reason and date therapy was stopped, type of healthcare provider … and where, and • Reason therapy was extended for more than 12 months.
  8. www.ahrq.gov/sites/default/files/2024-01/higginson-report.pdf
    January 01, 2024 - Borrowing medications from one resident’s supply to sustain treatment for another resident when the … receives a drug prescribed that is not clinically indicated (contraindicated, known allergy, duplicate therapy … Error Category Wrong drug 7.3 5.0 4.1 6/4,481 or .001 Known allergy 11.7 12.9 14.4 Duplicate therapy … Orders Rate of Errors per 1000 Doses Wrong drug 0.6 1.2 1.3 Known allergy 1.5 0.9 Duplicate therapy
  9. www.ahrq.gov/sites/default/files/2024-02/kleinman-report.pdf
    January 01, 2024 - Hospitalization for a Mental Illness, (6) Initiation and Engagement of Alcohol and Other Drug Dependence Treatment … a clinical rationale to allow for medications to be titrated up or down when used concurrently in therapy … the frequency or severity of the side effects but generally would not require a major alteration in therapy … interaction may result in an exacerbation of the patient's condition and/or require an alteration in therapy … Therefore, one interpretation of these data is that in vivo therapeutic trials are a common attempt
  10. www.ahrq.gov/sites/default/files/2024-04/maraganore-report.pdf
    January 01, 2024 - patient was eligible for enrollment in a comparative effectiveness pragmatic trial that assigned a treatment … survival free at 12 months of discontinuation of the assigned drug or the prescription of an adjunctive therapy … Some initial programming errors in treatment assignments were resolved. … as captured by the EMR (Failure = the assigned treatment failed, Success = the assigned treatment succeed … , Pending = the assigned treatment outcome is pending).
  11. www.ahrq.gov/sites/default/files/2024-07/earp-report.pdf
    January 01, 2024 - This includes the sharing of decision making, risks, cost effectiveness, treatment regimens, goals and … of health disciplines, including health policy and administration, pharmacy, nursing, occupational therapy
  12. www.ahrq.gov/sites/default/files/2024-04/etchegaray-report.pdf
    January 01, 2024 - o Debriefings need to be done by trained professionals, because they can turn into therapy sessions
  13. www.ahrq.gov/sites/default/files/2024-07/nuckols-report.pdf
    January 01, 2024 - Affordable Care Act; poor health literacy, which reduces patients’ abilities to benefit from effective therapy … ; and diseases, such as cancer, for which more effective treatments would be highly valued.
  14. www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/workplace-safety/workplace_safety_pilotstudyreport.pdf
    November 01, 2021 - Clinical Services Pathology, Lab 233 3% Pharmacy 264 4% Radiology, Imaging 240 3% Respiratory Therapy
  15. www.ahrq.gov/sites/default/files/wysiwyg/action-alliance/public-action-alliance-slides-040323_LOCKED.pdf
    May 25, 2023 - Medical Group Locations 73 Ambulatory Surgery Centers 185 Imaging Locations 302 Physical Therapy
  16. www.ahrq.gov/sites/default/files/wysiwyg/action-alliance/addressing-workforce-safety-chat-062723.pdf
    June 27, 2023 - a CARE Team as peer support for WPV events from Bridget Evans to everyone: 2:46 PM That's a therapy
  17. www.ahrq.gov/sites/default/files/wysiwyg/sops/quality-patient-safety/patientsafetyculture/healthitpatientsafetyitemset-hospitals-pilottestreport.pdf
    March 01, 2018 - Services Number Percent Pathology, Lab 241 3% Pharmacy 216 2% Radiology, Imaging 422 5% Respiratory Therapy
  18. www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/hsops2-pilot-results-parti.pdf
    September 01, 2019 - 18 <1% Pre Op, Operating Room/Suite, PACU/Post Op, Peri Op 239 6% Clinical Services Respiratory Therapy
  19. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Cook.pdf
    January 01, 2004 - However, when the case studies contained errors associated with diagnosis and/or treatment, included … in the Institute of Medicine’s definitions of errors (delays in treatment; use of outmoded treatments … Nurses who responded to the case studies were also hesitant to designate treatment and diagnostic issues … For example, participating pharmacists who encountered problems in the management of warfarin therapies … Although health care research has traditionally relied on experimental, control/treatment group design
  20. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Shah_99.pdf
    March 23, 2008 - other than substandard care included: (a) “Doing harm without consideration of alternative medical therapies … “Doing harm without consideration of alternative medical therapies, or inattention to procedure/clinical … “Not offering proper use of treatment when necessary due to absence, or failed application.” … : Patient has severe asthma Standard of care: Provision of steroids “Not entertaining a possible treatment … Patient has severe asthma Standard of care: Provision of steroids “Not entertaining a possible treatment

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: